BeStock  

Labcorp Holdings LH

US equityMarket cap rank #498Diagnostics & ResearchInfectious DiseaseCRO
$307.90 −$0.21 (-0.07%)
Market open · Oct 1, 11:50 am ET · After hours $308.11 0.00%
Open$305.99
Prev close$308.11
Day range$304.14 – $309.40
Volume96.0K
Market cap$24.97B
P/E (TTM)25.5
Dividend yield0.94%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$3.73B+5.8% YoY
Operating profit$456.70M+14.6% YoY
Net profit$299.10M+25.5% YoY
Diluted EPS$3.64+28.2% YoY
Free cash flow$313.90M-42.2% YoY
Operating cash flow$445.50M

Revenue, last 8 quarters

$3.3BSep '24$3.3BDec '24$3.3BMar '25$3.5BJun '25$3.6BSep '25$3.5BDec '25$3.5BMar '26$3.7BJun '26

Net profit, last 8 quarters

$169.6MSep '24$143.6MDec '24$213.0MMar '25$238.3MJun '25$261.5MSep '25$164.9MDec '25$278.0MMar '26$299.1MJun '26

Diluted EPS by quarter

2.00Sep '241.70Dec '242.52Mar '252.84Jun '253.12Sep '251.98Dec '253.35Mar '263.64Jun '26

Free cash flow by quarter

$161.5MSep '24$665.1MDec '24$-107.5MMar '25$542.7MJun '25$280.5MSep '25$490.3MDec '25$70.5MMar '26$313.9MJun '26

Annual revenue

$14.0BFY20$13.1BFY21$11.9BFY22$12.2BFY23$13.0BFY24$14.0BFY25

Profitability & balance sheet

Gross margin28.9%
Operating margin11.4%
Net margin7.0%
Return on equity11.7%
Return on assets5.5%
Return on invested capital7.8%
Current ratio1.80
Liabilities / assets53.5%
Cash & investments$141.80M
Total debt$6.58B
Net cash (debt)-$6.44B
Free cash flow / sales8.1%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $3.73B $3.54B $13.95B $3.52B $3.56B
Total Operating Revenue $3.73B $3.54B $13.95B $3.52B $3.56B
Cost of Revenue $2.62B $2.52B $9.94B $2.52B $2.54B
Gross Profit $1.11B $1.01B $4.01B $993.20M $1.03B
Operating Expense $655.30M $626.60M $2.50B $611.20M $621.90M
Selling and Admin Expenses $577.20M $551.00M $2.22B $538.60M $552.40M
Depreciation & Amortization & Depletion $78.10M $75.60M $280.00M $72.60M $69.50M
-Depreciation & Amortization $78.10M $75.60M $280.00M $72.60M $69.50M
Operating Profit $456.70M $387.20M $1.52B $382.00M $403.20M
Net Non-Operating Interest Income (Expense) -$61.10M -$55.10M -$224.10M -$55.00M -$56.00M
Non-Operating Interest Expense $61.10M $55.10M $224.10M $55.00M $56.00M
Other Income (Expense) -$9.20M -$12.40M -$184.60M -$136.40M -$10.20M
Gain on Sale of Security $5.60M $12.20M $15.20M $3.50M $3.50M
Earnings from Equity Interest -$6.20M -$5.10M -$13.30M -$6.10M -$5.20M
Special Income (Charges) -$5.10M -$6.40M -$131.50M -$114.40M -$6.60M
-Less:Restructuring and Mergern & Acquisition $5.10M $6.40M $127.20M $110.80M $5.90M
Other Non-Operating Income (Expenses) -$3.50M -$13.10M -$55.00M -$19.40M -$1.90M
Pretax Profit $386.40M $319.70M $1.11B $190.60M $337.00M
Tax $87.30M $41.70M $229.80M $25.70M $75.50M
Net Profit $299.10M $278.00M $877.70M $164.90M $261.50M
Profit from Continuing Operations $299.10M $278.00M $877.70M $164.90M $261.50M
Minority Interests $400,000.00 $200,000.00 $1.20M $200,000.00 $400,000.00
Net Income to Parent Company $298.70M $277.80M $876.50M $164.70M $261.10M
Net Income to Common Stockholders $298.70M $277.80M $876.50M $164.70M $261.10M
Basic EPS $3.66 $3.37 $10.54 $2.00 $3.14
Diluted EPS $3.64 $3.35 $10.46 $1.98 $3.12
Dividend Per Share $0.72 $0.72 $2.88 $0.72 $0.72
-Less:Impairment of Capital Assets – – $4.30M $3.60M $700,000.00
Net Income from Discontinuous Operations – – $0.00 – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $18.53B $19.09B $18.39B $18.39B $18.26B
Total Current Assets $3.81B $4.56B $4.02B $4.02B $4.08B
Cash and Cash Equivalents & Short-Term Investments $141.80M $981.10M $532.30M $532.30M $598.10M
-Cash and Cash Equivalents $141.80M $981.10M $532.30M $532.30M $598.10M
Receivables $2.50B $2.45B $2.26B $2.26B $2.27B
-Accounts Receivable $2.34B $2.29B $2.10B $2.10B $2.11B
-Other Receivables $162.40M $161.90M $156.90M $156.90M $156.10M
Inventory $562.20M $497.70M $534.70M $534.70M $521.50M
Other Current Assets $606.10M $629.50M $692.80M $692.80M $694.00M
Total Non-Current Assets $14.72B $14.53B $14.37B $14.37B $14.18B
Net PPE $3.10B $3.07B $3.08B $3.08B $3.11B
Investments and Advances $139.30M $146.60M $153.90M $153.90M $168.20M
-Long Term Equity Investment $139.30M $146.60M $153.90M $153.90M $168.20M
Goodwill and Other Intangible Assets $10.71B $10.59B $10.39B $10.39B $10.25B
-Goodwill $7.03B $6.96B $6.79B $6.79B $6.68B
-Other Intangible Assets $3.68B $3.64B $3.60B $3.60B $3.57B
Other Non-Current Assets $769.30M $724.90M $751.30M $751.30M $648.10M
Total Liabilities $9.91B $10.34B $9.76B $9.76B $9.55B
Total Current Liabilities $2.12B $2.64B $2.82B $2.82B $2.63B
Payables $688.50M $695.70M $1.00B $1.00B $668.50M
-Accounts Payable $688.50M $695.70M $840.80M $840.80M $668.50M
Current Accrued Expenses $862.40M $851.90M $263.60M $263.60M $878.00M
Short-Term Debt and Capital Lease Obligation $185.90M $688.20M $695.80M $695.80M $691.10M
-Current Debt $900,000.00 $500.40M $500.10M $500.10M $499.90M
-Current Capital Lease Obligation $185.00M $187.80M $195.70M $195.70M $191.20M
Current Deferred Liabilities $387.80M $405.20M $439.10M $439.10M $391.60M
Total Non-Current Liabilities $7.78B $7.70B $6.93B $6.93B $6.92B
Long Term Debt and Capital Lease Obligation $6.58B $6.55B $5.83B $5.83B $5.84B
-Long Term Debt $5.86B $5.83B $5.08B $5.08B $5.08B
-Long Term Capital Lease Obligation $722.60M $718.70M $745.60M $745.60M $756.30M
Non-Current Deferred Liabilities $486.70M $456.40M $605.00M $605.00M $441.50M
Other Non-Current Liabilities $717.60M $691.80M $112.10M $112.10M $639.10M
Total Equity $8.62B $8.75B $8.64B $8.64B $8.71B
Stockholders' Equity $8.61B $8.73B $8.62B $8.62B $8.70B
Capital Stock $7.30M $7.40M $7.50M $7.50M $7.50M
-Common Stock $7.30M $7.40M $7.50M $7.50M $7.50M
Additional Paid-In Capital $0.00 $0.00 $0.00 $0.00 $33.00M
Retained Earnings $8.70B $8.78B $8.64B $8.64B $8.70B
Gains/Losses Not Affecting Retained Earnings -$101.90M -$63.20M -$27.60M -$27.60M -$42.00M
Minority Interests $16.40M $16.90M $16.90M $16.90M $16.10M
-Gross PPE – – $6.35B $6.35B –
-Accumulated Depreciation – – -$3.27B -$3.27B –
-Total Tax Payable – – $160.30M $160.30M –
Derivative Product Liabilities – – $274.00M $274.00M –
Employee Benefits – – $111.20M $111.20M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $445.50M $191.50M $1.64B $614.20M $387.20M
Net cash flow from continuing operations $445.50M $191.50M $1.64B $614.20M $387.20M
Net Income from Continuing Operations $299.10M $278.00M $877.70M $164.90M $261.50M
Depreciation & Depletion & Amortization $179.00M $173.30M $681.10M $173.00M $171.00M
Deferred Tax $24.40M $2.00M $97.60M $21.20M $88.60M
Other Non-Cash Items $63.30M $59.40M $380.10M $179.30M $55.30M
Change in Working Capital -$155.20M -$352.90M -$526.10M $42.50M -$219.10M
-Change in Receivables -$59.90M -$194.10M -$122.20M $4.30M $8.60M
-Change in Inventory -$65.10M $35.40M -$30.20M -$12.30M -$14.40M
-Change in Prepaid Assets $23.10M $4.00M -$25.20M -$41.00M -$42.00M
-Change in Payables and Accrued Expense -$35.70M -$166.10M -$383.10M $44.30M -$167.40M
-Change In Other Working Capital -$17.60M -$32.10M $34.60M $47.20M -$3.90M
Net cash flow from investing -$366.20M -$322.10M -$1.19B -$389.90M -$374.00M
Net Cash Flow from Continuing Investing Activities -$366.20M -$322.10M -$1.19B -$389.90M -$374.00M
Capital Expenditure -$131.60M -$121.00M -$434.50M -$123.90M -$106.70M
Net Business Purchase and Sale -$236.50M -$208.90M -$575.10M -$78.10M -$268.40M
Net Other Investing Changes $1.90M $7.80M $8.00M $4.50M $1.10M
Financing Cash Flow -$919.90M $580.50M -$1.46B -$290.40M -$59.50M
Net Cash Flow from Continuing Financing Activities -$919.90M $580.50M -$1.46B -$290.40M -$59.50M
Net Issuance Payments Of Debt -$500.00M $750.00M -$1.00B $0.00 $0.00
Net Common Stock Issuance -$353.80M -$98.00M -$450.00M -$225.00M -$25.00M
Cash Dividends Paid -$58.70M -$61.20M -$240.70M -$59.30M -$59.90M
Proceeds from Stock Option Exercised $1.80M $32.90M $54.30M $0.00 $28.60M
Net Other Financing Charges -$9.20M -$43.20M $179.40M -$6.10M -$3.20M
Ending Cash Balance $141.80M $981.10M $532.30M $532.30M $598.10M
Net Change in Cash -$840.60M $449.90M -$1.01B -$66.10M -$46.30M
Beginning Cash Balance $981.10M $532.30M $1.52B $598.10M $647.30M
Effect of Exchange Rate Changes $1.30M -$1.10M $24.10M $300,000.00 -$2.90M
Free Cash Flow $313.90M $70.50M $1.21B $490.30M $280.50M
Cash Flow from Discontinued Operating Activities – – $0.00 – –
Net Investment Purchase and Sale – – -$192.40M – –
Cash Flow from Discontinued Financing Activities – – $0.00 – –

Discussion

No comments yet — be the first to weigh in on LH.

Leave a comment

Scroll to Top